Related Experiment Video
Updated: Jul 3, 2026
04:06
Minimally Invasive Surgical Decompression of Occipital Nerves
Published on: September 13, 2024
Treatment for meralgia paraesthetica.
Nofal Khalil1, Alessia Nicotra, Wojtek Rakowicz
1Clinical Neurophysiology, West London Neurosciences Centre, Charing Cross Hospital, Fulham Palace Road, London, UK, W6 8RF. nofal.khalil@imperial.nhs.uk
The Cochrane Database of Systematic Reviews
|July 23, 2008
Summary
Meralgia paresthetica treatments like corticosteroid injections and surgery show high improvement rates in observational studies. However, evidence is limited due to a lack of randomized controlled trials, with some cases improving spontaneously.
Area of Science:
- Neurology
- Surgical Science
Background:
- Meralgia paresthetica is a condition with various common treatments.
- These include conservative management, corticosteroid injections, and surgical options.
Purpose of the Study:
- To evaluate the relative effectiveness of different meralgia paresthetica interventions.
- To assess the evidence supporting common treatment modalities.
Main Methods:
- Searched multiple databases (Cochrane, MEDLINE, EMBASE, CINAHL) for randomized controlled trials (RCTs).
- Identified observational studies due to the absence of RCTs, applying specific inclusion criteria.
- Extracted data independently from selected high-quality observational studies.
Main Results:
- No RCTs or quasi-RCTs were identified for meralgia paresthetica treatments.
- Observational studies reported high improvement rates: spontaneous (69%), corticosteroid injection (83%), nerve decompression surgery (88%), and neurectomy (94%).
- Iatrogenic cases showed a 97% recovery rate.
Conclusions:
- The evidence base for meralgia paresthetica treatments is weak due to the lack of RCTs.
- High improvement rates are reported in observational studies for injections and surgery, comparable to spontaneous recovery.
- Further high-quality research, including RCTs, is needed to definitively establish treatment efficacy.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:26Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...